BofA adds TMUS, REGN to Value 10 list, leaves Growth 10 untouched
Bank of America added T-Mobile (TMUS) and Regeneron (REGN) to its Value 10 portfolio for November, while leaving its Growth 10 list unchanged. The Value 10 portfolio is an equal-weighted quantitative model that filters S&P 500 stocks.
How this was made
The 30-second read
Why it matters
The new inclusions signal analyst confidence but are modest catalysts compared to earnings or M&A news.
Market read
The announcement may generate modest buying pressure for TMUS and REGN as value‑focused investors adjust portfolios.
What to watch
Potential that the inclusion reflects deeper valuation concerns not yet reflected in the stock price.
Background
Bank of America Securities publishes a monthly Value 10 list of S&P 500 stocks it deems undervalued.
Ticker impact
Bank of America added T-Mobile (TMUS) to its Value 10 list, indicating a fresh analyst endorsement.
modest upside as the market prices in the value‑list endorsement
Analyst list changes are modest catalysts; no immediate large‑scale transaction is disclosed.
Bank of America added Regeneron Pharmaceuticals (REGN) to its Value 10 list, signaling a new positive rating.
modest upside as investors react to the value‑list inclusion
List inclusion is a small‑scale catalyst; no material corporate event is announced.
Market effects
May slightly boost the broader telecom and biotech/value sectors as analysts adjust exposure.
U.S. market focus; no regional effect beyond U.S. equities.
Limited to investors tracking BofA's value list; no global macro impact.
Counterpoint
List additions often have limited price impact; investors may already price in the endorsement.
Key entities
- analystBank of America Securities
Provider of the Value 10 list.
- companyT-Mobile US, Inc.
Telecom operator added to the list.
- companyRegeneron Pharmaceuticals, Inc.
Biotech firm added to the list.
